|
Jakus Z, Németh T, Verbeek JS, et al. Critical but overlapping role of FcgammaRIII and FcgammaRIV in activation of murine neutrophils by immobilized immune complexes. J Immunol 2008; 180:618-29.
|
|
Masuda M, Miyoshi H, Kobatake S, et al. Increased soluble FcgammaRIIIa(Mphi) in plasma from patients with coronary artery diseases. Atherosclerosis 2006; 188: 377-83.
|
|
Li P, Nagarajan S, Zhu C, et al. Recombinant CD16A-Ig forms a homodimer and cross-blocks the ligand binding functions of neutrophil and monocyte Fcgamma receptors. Mol Immunol 2002; 38:527-38.
|
|
Siiman O, Burshteyn A, Concepcion O, et al. Competitive antibody binding to soluble CD16B antigen and CD16B antigen on neutrophils in whole blood by flow cytometry. Cytometry 2001; 44:30-7.
|
|
Taylor DR, Parkin ET, Cocklin SL, et al. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 2009; 284:22590-600.
|
|
Lauc G, Heffer-Lauc M. Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochim Biophys Acta 2006; 1760:584-602.
|
|
Middelhoven PJ, Van Buul JD, Hordijk PL, et al. Different proteolytic mechanisms involved in Fc gammaR IIIb shedding from human neutrophils. Clin Exp Immunol 2001; 125:169-75.
|
|
Moldovan I, Galon J, Maridonneau-Parini I, et al. Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions. Immunol Lett 1999; 68:125-34.
|
|
Peng M, Guo S, Yin N, et al. Ectodomain shedding of Fcα receptor is mediated by ADAM10 and ADAM17. Immunology 2010; 130:83-91.
|
|
Thorp E, Vaisar T, Subramanian M, et al. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem 2011; 286:33335-44.
|
|
Yin N, Peng M, Xing Y, et al. Intracellular pools of FcαR (CD89) in human neutrophils are localized in tertiary granules and secretory vesicles, and two FcαR isoforms are found in tertiary granules. J Leukoc Biol 2007; 82: 551-8.
|
|
Lemieux GA, Blumenkron F, Yeung N, et al. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem 2007; 282:14836-44.
|
|
Xue J, Zhao Q, Zhu L, et al. Deglycosylation of FcalphaR at N58 increases its binding to IgA. Glycobiology 2010; 20: 905-15.
|
|
Reiss K, Maretzky T, Ludwig A, et al. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta- catenin nuclear signalling. EMBO J 2005; 24:742-52.
|
|
Maretzky T, Schulte M, Ludwig A, et al. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol 2005; 25:9040-53.
|
|
Le Gall SM, Bobé P, Reiss K, et al. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell 2009; 20:1785-94.
|
|
Bret C, Hose D, Reme T, et al. Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment. Exp Hematol 2011; 39:546-57.
|
|
Dehmel T, Janke A, Hartung HP, et al. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies. Neurobiol Dis 2007; 25:665- 74.
|
|
Willcocks LC, Lyons PA, Clatworthy MR, et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008; 205: 1573-82.
|
|
Morris DL, Roberts AL, Witherden AS, et al. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet 2010; 18:1027-31.
|
|
Nagarajan S, Fifadara NH, Selvaraj P. Signal-specific activation and regulation of human neutrophil Fc gamma receptors. J Immunol 2005; 174:5423-32.
|
|
Masuda M, Morimoto T, Kobatake S, et al. Measurement of soluble Fcgamma receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clin Exp Immunol 2003; 132:477-84.
|